Oestrogen_NN
receptor_NN
-LRB-_-LRB-
ER_NN
-RRB-_-RRB-
analysis_NN
in_IN
B-cell_NN
chronic_JJ
lymphocytic_JJ
leukemia_NN
:_:
correlation_NN
of_IN
biochemical_JJ
and_CC
immunocytochemical_JJ
methods_NNS
._.

Oestrogen_NN
receptors_NNS
-LRB-_-LRB-
ER_NN
-RRB-_-RRB-
are_VBP
present_JJ
in_IN
neoplastic_JJ
lymphoid_JJ
cells_NNS
and_CC
have_VBP
been_VBN
considered_VBN
a_DT
physiological_JJ
marker_NN
of_IN
growth_NN
rate_NN
or_CC
differentiation_NN
._.

Tamoxifen_NN
,_,
an_DT
estrogen_NN
antagonist_NN
,_,
has_VBZ
been_VBN
given_VBN
in_IN
some_DT
patients_NNS
with_IN
CLL_NN
and_CC
Hodgkin_NN
's_POS
disease_NN
,_,
with_IN
dramatic_JJ
response_NN
in_IN
single_JJ
cases_NNS
._.

Until_IN
now_RB
,_,
ER_NN
status_NN
has_VBZ
been_VBN
assessed_VBN
using_VBG
a_DT
steroid_NN
binding_NN
assay_NN
-LRB-_-LRB-
SBA_NN
-RRB-_-RRB-
which_WDT
has_VBZ
many_JJ
inherent_JJ
problems_NNS
._.

Recently_RB
,_,
the_DT
development_NN
of_IN
monoclonal_JJ
antibodies_NNS
directed_VBN
against_IN
ER_NN
has_VBZ
been_VBN
applied_VBN
to_TO
the_DT
study_NN
of_IN
breast_NN
carcinomas_NNS
and_CC
results_NNS
obtained_VBN
show_VBP
good_JJ
correlation_NN
with_IN
the_DT
quantitative_JJ
SBA_NN
._.

We_PRP
studied_VBD
49_CD
cases_NNS
of_IN
B-cell_NN
chronic_JJ
lymphocytic_JJ
leukemia_NN
-LRB-_-LRB-
CLL_NN
-RRB-_-RRB-
using_VBG
immunostaining_NN
of_IN
cytospin_NN
preparations_NNS
._.

In_IN
30_CD
of_IN
these_DT
cases_NNS
ER_NN
enzyme_NN
immunoassay_NN
-LRB-_-LRB-
ER-EIA_NN
-RRB-_-RRB-
was_VBD
also_RB
performed_VBN
._.

Cultured_VBN
MCF-7_NN
cells_NNS
,_,
derived_VBN
from_IN
a_DT
pleural_JJ
effusion_NN
of_IN
a_DT
breast_NN
cancer_NN
patient_NN
,_,
known_VBN
to_TO
contain_VB
high_JJ
levels_NNS
of_IN
ER_NN
were_VBD
used_VBN
as_IN
a_DT
positive_JJ
control_NN
-LRB-_-LRB-
40-48_CD
%_NN
ER_NN
positive_JJ
cells_NNS
by_IN
immunocytochemistry_NN
;_:
200_CD
fmol\/mg_NN
protein_NN
by_IN
EIA_NN
-RRB-_-RRB-
._.

All_DT
of_IN
the_DT
CLL_NN
cases_NNS
except_IN
two_CD
-LRB-_-LRB-
96_CD
%_NN
-RRB-_-RRB-
were_VBD
negative_JJ
for_IN
ER_NN
-LRB-_-LRB-
less_JJR
than_IN
1_CD
%_NN
staining_NN
;_:
less_JJR
than_IN
4_CD
fmol\/mg_NN
protein_NN
-RRB-_-RRB-
._.

The_DT
two_CD
positive_JJ
cases_NNS
expressed_VBD
granular_JJ
ER_NN
staining_NN
over_IN
the_DT
nucleus_NN
-LRB-_-LRB-
9.2_CD
and_CC
12.1_CD
%_NN
positive_JJ
cells_NNS
-RRB-_-RRB-
and_CC
were_VBD
positive_JJ
by_IN
EIA_NN
and_CC
SBA_NN
._.

It_PRP
is_VBZ
concluded_VBN
that_IN
-LRB-_-LRB-
i_LS
-RRB-_-RRB-
patients_NNS
with_IN
CLL_NN
rarely_RB
express_VBP
ER_NN
and_CC
-LRB-_-LRB-
ii_LS
-RRB-_-RRB-
immunocytochemical_JJ
staining_NN
of_IN
cytospin_NN
preparations_NNS
is_VBZ
a_DT
valid_JJ
technique_NN
for_IN
the_DT
measurement_NN
of_IN
ER_NN
._.

It_PRP
is_VBZ
of_IN
interest_NN
that_IN
one_CD
of_IN
the_DT
positive_JJ
cases_NNS
was_VBD
diagnosed_VBN
as_IN
CLL_NN
with_IN
Richter_NN
's_POS
transformation_NN
confirming_VBG
earlier_JJR
findings_NNS
._.

